Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin W Southern

Showing results (51-60 of 119) with videos related to

Pageof 12
Sort By:
The Cochrane Database of Systematic Reviews|August 3, 2018
Correctors (specific therapies for class II CFTR mutations) for cystic fibrosisKevin W Southern, Sanjay Patel, Ian P Sinha, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|September 19, 2024
Regulatory adverse drug reaction analyses support a temporal increase in psychiatric reactions after initiation of cystic fibrosis combination modulator therapiesJacob O'Connor, Dilip Nazareth, Dennis Wat, et al.
The Cochrane Database of Systematic Reviews|January 20, 2017
Ataluren and similar compounds (specific therapies for premature termination codon class I mutations) for cystic fibrosisAisha A Aslam, Colin Higgins, Ian P Sinha, et al.
The Cochrane Database of Systematic Reviews|November 16, 2012
Macrolide antibiotics for cystic fibrosisKevin W Southern, Pierre M Barker, Arturo Solis-Moya, et al.
The Cochrane Database of Systematic Reviews|May 7, 2026
CFTR modulator monotherapy for people with cystic fibrosis with class II CFTR gene variants (most commonly F508del)Matthew Heneghan, Sherie Smith, Nikki Jahnke, et al.
The Cochrane Database of Systematic Reviews|January 8, 2019
Potentiators (specific therapies for class III and IV mutations) for cystic fibrosisMica Skilton, Ashma Krishan, Sanjay Patel, et al.
BMJ Open Respiratory Research|January 30, 2025
Qualitative study exploring the views and perceptions of parents/carers of young children with CF regarding the introduction of CFTR modulator therapy (The REVEAL study; PaRents pErspectiVEs of KAftrio in chiLdren aged 2-5)Sioned Haf Davies, Faye Wade, Heather Fogg, et al.
Journal of Pediatric Surgery|February 18, 2014
Gastrointestinal surgery in cystic fibrosis: a 20-year reviewPaul J Farrelly, Caroline Charlesworth, Sophie Lee, et al.
Physiological Reports|January 9, 2014
Abnormal tracheal smooth muscle function in the CF mouseHelen L Wallace, Kevin W Southern, Marilyn G Connell, et al.
Thorax|November 28, 2019
Impact of newborn screening on outcomes and social inequalities in cystic fibrosis: a UK CF registry-based studyDaniela K Schlüter, Kevin W Southern, Carol Dryden, et al.
Pageof 12

Showing results (51-60 of 119) with videos related to

Sort By:
Pageof 12
The Cochrane Database of Systematic Reviews|August 3, 2018
Correctors (specific therapies for class II CFTR mutations) for cystic fibrosisKevin W Southern, Sanjay Patel, Ian P Sinha, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|September 19, 2024
Regulatory adverse drug reaction analyses support a temporal increase in psychiatric reactions after initiation of cystic fibrosis combination modulator therapiesJacob O'Connor, Dilip Nazareth, Dennis Wat, et al.
The Cochrane Database of Systematic Reviews|January 20, 2017
Ataluren and similar compounds (specific therapies for premature termination codon class I mutations) for cystic fibrosisAisha A Aslam, Colin Higgins, Ian P Sinha, et al.
The Cochrane Database of Systematic Reviews|November 16, 2012
Macrolide antibiotics for cystic fibrosisKevin W Southern, Pierre M Barker, Arturo Solis-Moya, et al.
The Cochrane Database of Systematic Reviews|May 7, 2026
CFTR modulator monotherapy for people with cystic fibrosis with class II CFTR gene variants (most commonly F508del)Matthew Heneghan, Sherie Smith, Nikki Jahnke, et al.
The Cochrane Database of Systematic Reviews|January 8, 2019
Potentiators (specific therapies for class III and IV mutations) for cystic fibrosisMica Skilton, Ashma Krishan, Sanjay Patel, et al.
BMJ Open Respiratory Research|January 30, 2025
Qualitative study exploring the views and perceptions of parents/carers of young children with CF regarding the introduction of CFTR modulator therapy (The REVEAL study; PaRents pErspectiVEs of KAftrio in chiLdren aged 2-5)Sioned Haf Davies, Faye Wade, Heather Fogg, et al.
Journal of Pediatric Surgery|February 18, 2014
Gastrointestinal surgery in cystic fibrosis: a 20-year reviewPaul J Farrelly, Caroline Charlesworth, Sophie Lee, et al.
Physiological Reports|January 9, 2014
Abnormal tracheal smooth muscle function in the CF mouseHelen L Wallace, Kevin W Southern, Marilyn G Connell, et al.
Thorax|November 28, 2019
Impact of newborn screening on outcomes and social inequalities in cystic fibrosis: a UK CF registry-based studyDaniela K Schlüter, Kevin W Southern, Carol Dryden, et al.
Pageof 12